Владимир Павлович Жердев
191 works · 295 citations · h-index 8
Top works
- Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo‐prolylglycine in rat brain
- Species differences in phenazeram kinetics and metabolism
- The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-l-prolylglycine
- 7-Bromo-5-(2′-chlorophenyl)-1, 3-dihydro-2H-1, 4-benzodiazepin-2-one (I), a new tranquillizing agent: metabolism in rats
- Tissue availability of afobazole and its major metabolites in rats
- Regional and Subcellular Localization of Cycloprolylglycine in Rat Brain
- Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration
- Method of quantitative gas-chromatographic determination of phenazepam and its metabolite 3-hydroxyphenazepam in plasma
- Assay of caffeine and its metabolites in the rat blood plasma using HPLC as a method for determination of metabolic ratios
- Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115
- Disribution kinetics of cardioprotector ALM-802 in rat organs and tissues
- Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats
- Поиск взаимосвязи между анксиолитическим действием оригинального производного пирроло [1,2-a] пиразина, лиганда TsPO - ГМЛ-1 и его концентрациями в плазме крови крыс
- Development and Validation of the Quantification of GML-1 Compound (N-benzyl-N-methyl-1-phenylpyrrolo[1,2-A] pyrazine- 3-carbamide) in the Blood Plasma of Rats by HPLC–MS
- Quantification of a potential anticonvulsant drug GIZh-298 in rat plasma by liquid chromatography-mass spectrometry
- Фармакокинетика потенциального противоэпилептического фармакологического вещества ГИЖ-298 у крыс
- Relationship between physicochemical characteristics and pharmacokinetic parameters of 1,4-benzodiazepine derivatives
- Excretion of afobazole and its metabolites with urine and feces in rats
- Experimental pharmacokinetics of a new antiparkinsonian drug ADK-1113
- [Cytisine pharmacokinetics when used in a transdermal therapeutic system in rabbits].